Janelle Ashton

649 total citations
16 papers, 475 citations indexed

About

Janelle Ashton is a scholar working on Pharmacology, Physiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Janelle Ashton has authored 16 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 5 papers in Physiology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Janelle Ashton's work include Reproductive Health and Contraception (4 papers), Smoking Behavior and Cessation (3 papers) and Pharmacology and Obesity Treatment (2 papers). Janelle Ashton is often cited by papers focused on Reproductive Health and Contraception (4 papers), Smoking Behavior and Cessation (3 papers) and Pharmacology and Obesity Treatment (2 papers). Janelle Ashton collaborates with scholars based in New Zealand, Netherlands and United States. Janelle Ashton's co-authors include Mira Harrison‐Woolrych, David M Coulter, Peter Herbison, Philip W. Brownjohn, Helen Paterson, Keren Skegg, D C Skegg, Ming Tan, Ruth Savage and Simran Maggo and has published in prestigious journals such as Neuroscience, The British Journal of Psychiatry and Vaccine.

In The Last Decade

Janelle Ashton

16 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Janelle Ashton New Zealand	12	161	116	89	84	81	16	475
Shi Lin Lin Hong Kong	15	168 1.0×	112 1.0×	34 0.4×	18 0.2×	105 1.3×	25	562
Mette Lausten Hansen Denmark	6	134 0.8×	75 0.6×	23 0.3×	32 0.4×	31 0.4×	11	403
Jochen G.W. Theis Canada	11	365 2.3×	292 2.5×	56 0.6×	62 0.7×	35 0.4×	19	677
Annelienke M. van Hulst Netherlands	9	176 1.1×	76 0.7×	27 0.3×	67 0.8×	38 0.5×	17	373
Pat Tennis United States	6	83 0.5×	187 1.6×	29 0.3×	210 2.5×	21 0.3×	6	483
Nasrin Matinnia Iran	11	110 0.7×	152 1.3×	198 2.2×	27 0.3×	13 0.2×	35	518
Stephanie Pirotta Australia	11	214 1.3×	30 0.3×	61 0.7×	12 0.1×	50 0.6×	29	436
Júlia Ojuel Spain	14	313 1.9×	329 2.8×	195 2.2×	23 0.3×	31 0.4×	23	768
Emily Johnson United States	9	108 0.7×	275 2.4×	130 1.5×	62 0.7×	18 0.2×	18	674

Countries citing papers authored by Janelle Ashton

Since Specialization

Citations

This map shows the geographic impact of Janelle Ashton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janelle Ashton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janelle Ashton more than expected).

Fields of papers citing papers by Janelle Ashton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janelle Ashton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janelle Ashton. The network helps show where Janelle Ashton may publish in the future.

Co-authorship network of co-authors of Janelle Ashton

This figure shows the co-authorship network connecting the top 25 collaborators of Janelle Ashton. A scholar is included among the top collaborators of Janelle Ashton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janelle Ashton. Janelle Ashton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Braund, Rhiannon, et al.. (2020). Synthetic cannabis: adverse events reported to the New Zealand Pharmacovigilance Centre. Clinical Toxicology. 59(6). 472–479. 10 indexed citations

Harrison‐Woolrych, Mira, Simran Maggo, Ming Tan, Ruth Savage, & Janelle Ashton. (2011). Cardiovascular Events in Patients taking Varenicline. Drug Safety. 35(1). 33–43. 24 indexed citations

Harrison‐Woolrych, Mira, Keren Skegg, Janelle Ashton, Peter Herbison, & D C Skegg. (2011). Nocturnal enuresis in patients taking clozapine, risperidone, olanzapine and quetiapine: comparative cohort study. The British Journal of Psychiatry. 199(2). 140–144. 41 indexed citations

Brownjohn, Philip W. & Janelle Ashton. (2011). Spinal cannabinoid CB2 receptors as a target for neuropathic pain: an investigation using chronic constriction injury. Neuroscience. 203. 180–193. 45 indexed citations

Harrison‐Woolrych, Mira & Janelle Ashton. (2011). Psychiatric Adverse Events Associated with Varenicline. Drug Safety. 34(9). 763–772. 38 indexed citations

Harrison‐Woolrych, Mira & Janelle Ashton. (2010). Utilization of the smoking cessation medicine varenicline: an intensive post‐marketing study in New Zealand. Pharmacoepidemiology and Drug Safety. 19(9). 949–953. 13 indexed citations

Harrison‐Woolrych, Mira, Janelle Ashton, & Peter Herbison. (2010). Fatal and Non-Fatal Cardiovascular Events in a General Population Prescribed Sibutramine in New Zealand. Drug Safety. 33(7). 605–613. 20 indexed citations

Paterson, Helen, Janelle Ashton, & Mira Harrison‐Woolrych. (2009). A nationwide cohort study of the use of the levonorgestrel intrauterine device in New Zealand adolescents. Contraception. 79(6). 433–438. 56 indexed citations

Tatley, Michael, Anne McNicholas, Lifeng Zhou, et al.. (2008). The Intensive Vaccines Monitoring Programme (IVMP): An electronic system to monitor vaccine safety in New Zealand. Vaccine. 26(22). 2746–2752. 12 indexed citations

10.

Harrison‐Woolrych, Mira, et al.. (2007). Safety and Usage of Atypical Antipsychotic Medicines in Children. Drug Safety. 30(7). 569–579. 46 indexed citations

11.

Ashton, Janelle, et al.. (2007). Sibutramine usage in New Zealand: an analysis of prescription data by the Intensive Medicines Monitoring Programme. Pharmacoepidemiology and Drug Safety. 16(11). 1217–1226. 6 indexed citations

12.

Paterson, Helen, et al.. (2007). Hair loss with use of the levonorgestrel intrauterine device. Contraception. 76(4). 306–309. 16 indexed citations

13.

Harrison‐Woolrych, Mira, Peter Herbison, Rachael McLean, Janelle Ashton, & Jim Slattery. (2005). Incidence of Thrombotic Cardiovascular Events in Patients Taking Celecoxib Compared with Those Taking Rofecoxib. Drug Safety. 28(5). 435–442. 9 indexed citations

14.

Harrison‐Woolrych, Mira, Janelle Ashton, & David M Coulter. (2003). Uterine perforation on intrauterine device insertion: is the incidence higher than previously reported?. Contraception. 67(1). 53–56. 122 indexed citations

15.

Harrison‐Woolrych, Mira, Janelle Ashton, & David M Coulter. (2002). Insertion of the Multiload Cu375 intrauterine device; experience in over 16,000 New Zealand women. Contraception. 66(6). 387–391. 15 indexed citations

16.

Ghose, Karabi, et al.. (1995). Possible Interaction of Roxithromycin with Warfarin. Clinical Drug Investigation. 10(5). 302–309. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact